home / stock / antx / antx message board
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ANTX News Article - AN2 Therapeutics to Present at Upcoming Investor Conferences | whytestocks | investorshangout | 11/02/2022 8:20:48 PM |
whytestocks: $ANTX News Article - NIH Awards Contract to AN2 Therapeutics Valued Up to $17.8 Million | whytestocks | investorshangout | 09/29/2022 2:05:48 PM |
whytestocks: $ANTX News Article - AN2 Therapeutics Reports Second Quarter 2022 Financial Results and | whytestocks | investorshangout | 08/11/2022 8:40:52 PM |
whytestocks: $ANTX News Article - AN2 Therapeutics Reports First Quarter 2022 Financial Results and | whytestocks | investorshangout | 05/10/2022 8:35:52 PM |
whytestocks: $ANTX News Article - AN2 Therapeutics Appoints Maggie FitzPatrick to Its Board of Direc | whytestocks | investorshangout | 05/09/2022 12:30:49 PM |
News, Short Squeeze, Breakout and More Instantly...
AN2 Therapeutics Inc. Company Name:
ANTX Stock Symbol:
NYSE Market:
2024-04-02 05:30:04 ET JMP Securities analyst issues OUTPERFORM recommendation for ANTX on April 2, 2024 02:23AM ET. ANTX was trading at $3.76 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recom...
Phase 2/3 trial (EBO-301) in treatment-refractory Mycobacterium avium Complex (TR-MAC) continues with Phase 2 topline results expected in summer 2024 and Phase 3 enrollment pause in place during continued analysis of incoming data; plan to discuss with FDA Cash, cash equivalents, and inve...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...